Community Academic Profiles–

Marcia L. Stefanick, Ph.D.

Back to Profile

Publication Details

  • Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women's Health Initiative randomized trial.

    Cauley JA, Robbins J, Chen Z, Cummings SR, Jackson RD, LaCroix AZ, LeBoff M, Lewis CE, McGowan J, Neuner J, Pettinger M, Stefanick ML, Wactawski-Wende J, Watts NB. JAMA. 2003; 290 (13): 1729-38

    In the Women's Health Initiative trial of estrogen-plus-progestin therapy, women assigned to active treatment had fewer fractures.

    PubMedID: 14519707

Stanford Medicine Resources:

Footer Links: